← All Posts
Edwards Lifesciences Corporation
May 08, 2026
•
Author: Phil Ratcliff
| Item |
Proposal |
Vote |
| 1 |
Election of Directors |
|
| 1.01 |
Leslie C. Davis |
✓ For(240.525)
|
| 1.02 |
David T. Feinberg, MD |
✓ For(240.525)
|
| 1.03 |
Kieran T. Gallahue |
✓ For(240.525)
|
| 1.04 |
Leslie S. Heisz |
✓ For(240.525)
|
| 1.05 |
Paul A. LaViolette |
✓ For(240.525)
|
| 1.06 |
Steven R. Loranger |
✓ For(240.525)
|
| 1.07 |
Ramona Sequeira |
✓ For(240.525)
|
| 1.08 |
Nicholas J. Valeriani |
✓ For(240.525)
|
| 1.09 |
Bernard Zovighian |
✗ Against(240.525)
|
| 2 |
Advisory Vote to Approve Named Executive Officer Compensation |
✓ For(240.525)
|
| 3 |
Ratification of Appointment of Independent Registered Public Accounting Firm |
✓ For(240.525)
|
| 4 |
Approval of the Amended and Restated Long-Term Stock Incentive Compensation Program |
✓ For(240.525)
|
This article was written for information purposes only and its content should not be
construed by any consumer and/or prospective client as rebel Financial's solicitation
to affect, or attempt to affect transactions in securities, or the rendering of
personalized investment advice for compensation. No client or prospective client should
assume that any such discussion serves as the receipt of, or a substitute for,
personalized advice from rebel Financial, or from any other investment professional.
See our disclosures page for more information.
rebel Financial